{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:29:01Z","timestamp":1782959341590,"version":"3.54.5"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,3,30]],"date-time":"2012-03-30T00:00:00Z","timestamp":1333065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s11906-012-0262-y","type":"journal-article","created":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T02:14:53Z","timestamp":1332987293000},"page":"209-218","source":"Crossref","is-referenced-by-count":43,"title":["Vitamin D and Cardiovascular Risk"],"prefix":"10.1007","volume":"14","author":[{"given":"Shweta R.","family":"Motiwala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,30]]},"reference":[{"key":"262_CR1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266\u201381.","journal-title":"N Engl J Med"},{"key":"262_CR2","first-page":"200","volume":"16","author":"R Bouillon","year":"1995","unstructured":"Bouillon R, Okamura WH, Norman AW. Structure-function relationships in the vitamin D endocrine system. Endocr Rev. 1995;16:200\u201357.","journal-title":"Endocr Rev"},{"key":"262_CR3","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1126\/science.505004","volume":"206","author":"WE Stumpf","year":"1979","unstructured":"Stumpf WE, Sar M, Reid FA, et al. Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science. 1979;206:1188\u201390.","journal-title":"Science"},{"key":"262_CR4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ajcn\/84.1.18","volume":"84","author":"HA Bischoff-Ferrari","year":"2006","unstructured":"Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84:18\u201328.","journal-title":"Am J Clin Nutr"},{"key":"262_CR5","volume-title":"Dietary references intakes for calcium and vitamin D","author":"Institute of Medicine","year":"2010","unstructured":"\u2022\u2022 Institute of Medicine. Dietary references intakes for calcium and vitamin D. Washington, DC: National Academies Press; 2010. These guidelines from the IOM provide recommendations regarding minimum daily intake of both calcium and vitamin D."},{"key":"262_CR6","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911\u201330.","journal-title":"J Clin Endocrinol Metab"},{"key":"262_CR7","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S8756-3282(02)00692-0","volume":"30","author":"AC Looker","year":"2002","unstructured":"Looker AC, Dawson-Hughes B, Calvo MS, et al. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone. 2002;30:771\u20137.","journal-title":"Bone"},{"key":"262_CR8","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archinternmed.2008.604","volume":"169","author":"AA Ginde","year":"2009","unstructured":"\u2022 Ginde AA, Liu MC, Camargo CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988\u20132004. Arch Intern Med. 2009;169:626\u201332. This large study of epidemiologic trends of vitamin D insufficiency suggests that its prevalence is increasing and that there are important racial and ethnic disparities that have persisted over time.","journal-title":"Arch Intern Med"},{"key":"262_CR9","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/jcb.10338","volume":"88","author":"MF Holick","year":"2003","unstructured":"Holick MF. Vitamin D: a millennium perspective. J Cell Biochem. 2003;88:296\u2013307.","journal-title":"J Cell Biochem"},{"key":"262_CR10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF02555253","volume":"41","author":"J Merke","year":"1987","unstructured":"Merke J, Hofmann W, Goldschmidt D, Ritz E. Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro. Calcif Tissue Int. 1987;41:112\u20134.","journal-title":"Calcif Tissue Int"},{"key":"262_CR11","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1161\/01.CIR.0000160353.27927.70","volume":"111","author":"D Somjen","year":"2005","unstructured":"Somjen D, Weisman Y, Kohen F, et al. 25-Hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation. 2005;111:1666\u201371.","journal-title":"Circulation"},{"key":"262_CR12","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1172\/JCI114097","volume":"83","author":"J Merke","year":"1989","unstructured":"Merke J, Milde P, Lewicka A, et al. Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3: studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest. 1989;83:1903\u201315.","journal-title":"J Clin Invest"},{"key":"262_CR13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1055\/s-2007-979027","volume":"29","author":"SB Zanello","year":"1997","unstructured":"Zanello SB, Collins ED, Marinissen MJ, et al. Vitamin D receptor expression in chicken muscle tissue and cultured myoblasts. Horm Metab Res. 1997;29:231\u20136.","journal-title":"Horm Metab Res"},{"key":"262_CR14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1210\/en.136.2.482","volume":"136","author":"TD O\u2019Connell","year":"1995","unstructured":"O\u2019Connell TD, Giacherio DA, Jarvis AK, Simpson RU. Inhibition of cardiac myocyte maturation by 1,25-dihydroxyvitamin D3. Endocrinology. 1995;136:482\u20138.","journal-title":"Endocrinology"},{"key":"262_CR15","first-page":"H1751","volume":"272","author":"TD O\u2019Connell","year":"1997","unstructured":"O\u2019Connell TD, Berry JE, Jarvis AK, et al. 1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol. 1997;272:H1751\u20138.","journal-title":"Am J Physiol"},{"key":"262_CR16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/CIRCULATIONAHA.109.856070","volume":"120","author":"J Oh","year":"2009","unstructured":"Oh J, Weng S, Felton SK, et al. 1,25(OH)2 Vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation. 2009;120:687\u201398.","journal-title":"Circulation"},{"key":"262_CR17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","volume":"110","author":"YC Li","year":"2002","unstructured":"Li YC, Kong J, Wei M, et al. 1,25-dihydroxyvitamin (D)3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229\u201338.","journal-title":"J Clin Invest"},{"key":"262_CR18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjhyper.2007.01.017","volume":"20","author":"R Scragg","year":"2007","unstructured":"Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens. 2007;20:713\u20139.","journal-title":"Am J Hypertens"},{"key":"262_CR19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.amjcard.2009.08.661","volume":"105","author":"RK Scragg","year":"2010","unstructured":"Scragg RK, Camargo Jr CA, Simpson R. Relation of serum 25-hydroxyvitamin D to heart rate and cardiac work (from the National Health and Nutrition Examination Surveys). Am J Cardiol. 2010;105:122\u20138.","journal-title":"Am J Cardiol"},{"key":"262_CR20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000330716","volume":"35","author":"C Sabanavagam","year":"2011","unstructured":"Sabanavagam C, Shankar A, Somasundaram S. Serum vitamin D level and prehypertension among subjects free of hypertension. Kidney Blood Press Res. 2011;35:106\u201313.","journal-title":"Kidney Blood Press Res"},{"key":"262_CR21","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/HYPERTENSIONAHA.107.087288","volume":"49","author":"JP Forman","year":"2007","unstructured":"Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007;49:1063\u20139.","journal-title":"Hypertension"},{"key":"262_CR22","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/HYPERTENSIONAHA.108.117630","volume":"52","author":"JP Forman","year":"2008","unstructured":"Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension. 2008;52:828\u201332.","journal-title":"Hypertension"},{"key":"262_CR23","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/HYPERTENSIONAHA.107.107821","volume":"51","author":"L Wang","year":"2008","unstructured":"Wang L, Manson JE, Buring JE, et al. Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension. 2008;51:1073\u20139.","journal-title":"Hypertension"},{"key":"262_CR24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/aje\/kwr274","volume":"175","author":"KL Margolis","year":"2012","unstructured":"Margolis KL, Martin LW, Ray RM, et al. A prospective study of serum 25-hydroxyvitamin D levels, blood pressure, and incident hypertension in postmenopausal women. Am J Epidemiol. 2012;175:22\u201332.","journal-title":"Am J Epidemiol"},{"key":"262_CR25","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1161\/HYPERTENSIONAHA.109.143990","volume":"55","author":"R Jorde","year":"2010","unstructured":"Jorde R, Figenschau Y, Emaus N, et al. Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension. 2010;55:792\u20138.","journal-title":"Hypertension"},{"key":"262_CR26","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/HJH.0b013e32834320f9","volume":"29","author":"A Burgaz","year":"2011","unstructured":"Burgaz A, Orsini N, Larsson SC, Wolk A. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens. 2011;29:636\u201345.","journal-title":"J Hypertens"},{"key":"262_CR27","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1681\/ASN.2009080872","volume":"21","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Kong J, Deb DK, et al. Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system. J Am Soc Nephrol. 2010;21:966\u201373.","journal-title":"J Am Soc Nephrol"},{"key":"262_CR28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ki.2008.101","volume":"74","author":"C Zhou","year":"2008","unstructured":"Zhou C, Lu F, Cao K, et al. Calcium-independent and 1,2(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout nice. Kidney Int. 2008;74:170\u20139.","journal-title":"Kidney Int"},{"key":"262_CR29","doi-asserted-by":"crossref","first-page":"29821","DOI":"10.1074\/jbc.M705495200","volume":"282","author":"W Yuan","year":"2007","unstructured":"Yuan W, Pan W, Kong J, et al. 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem. 2007;282:29821\u201330.","journal-title":"J Biol Chem"},{"key":"262_CR30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/0003-4819-105-5-649","volume":"105","author":"LM Resnick","year":"1986","unstructured":"Resnick LM, Muller FB, Laragh JH. Calcium-regulating hormones in essential hypertension: relation to plasma renin activity and sodium metabolism. Ann Intern Med. 1986;105:649\u201354.","journal-title":"Ann Intern Med"},{"key":"262_CR31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/1470320310391922","volume":"12","author":"A Vaidya","year":"2011","unstructured":"\u2022 Vaidya A, Forman JP, Hopkins PN, et al. 25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians. J Renin Angiotensin Aldosterone Syst. 2011;12:311\u201319. This is a cross-sectional analysis of hypertensive participants that confirms associations between vitamin D level, PRA, and salt sensitivity of blood pressure. It provides additional support for the proposed influence of vitamin D on the RAS.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"262_CR32","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/HYPERTENSIONAHA.109.140160","volume":"56","author":"A Vaidya","year":"2010","unstructured":"Vaidya A, Forman J. Vitamin D and hypertension: current evidence and future directions. Hypertension. 2010;56:774\u20139.","journal-title":"Hypertension"},{"key":"262_CR33","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/HYPERTENSIONAHA.108.114991","volume":"52","author":"KL Margolis","year":"2008","unstructured":"Margolis KL, Ray RM, Van Horn L, et al. Effect of calcium and vitamin D supplementation on blood pressure: the Women\u2019s Health Initiative Randomized Trial. Hypertension. 2008;52:847\u201355.","journal-title":"Hypertension"},{"key":"262_CR34","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2796.2009.02181.x","volume":"267","author":"R Jorde","year":"2010","unstructured":"Jorde R, Sneve M, Torjesen PA, et al. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1\u00a0year. J Intern Med. 2010;267:462\u201372.","journal-title":"J Intern Med"},{"key":"262_CR35","first-page":"640","volume":"49","author":"R Scragg","year":"1995","unstructured":"Scragg R, Khaw KT, Murphy S. Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr. 1995;49:640\u20136.","journal-title":"Eur J Clin Nutr"},{"key":"262_CR36","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1210\/jc.86.4.1633","volume":"86","author":"M Pfeifer","year":"2001","unstructured":"Pfeifer M, Begerow B, Minne HW, et al. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab. 2001;86:1633\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"262_CR37","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1097\/HJH.0b013e32832f075b","volume":"27","author":"MD Witham","year":"2009","unstructured":"Witham MD, Nadir MA, Struthers AD. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens. 2009;27:1948\u201354.","journal-title":"J Hypertens"},{"key":"262_CR38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.7326\/0003-4819-152-5-201003020-00009","volume":"152","author":"AG Pittas","year":"2010","unstructured":"\u2022 Pittas AG, Chung M, Trikalinos T, et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010;152:307\u201314. This meta-analysis includes observational and interventional studies investigating multiple cardiometabolic end points in response to vitamin D supplementation and UVB radiation. The trials showed no clinically significant effect of vitamin D supplementation at the doses studied, and the authors suggest that further well-designed randomized, prospective trials are necessary.","journal-title":"Ann Intern Med"},{"key":"262_CR39","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/SMJ.0b013e3181e6d389","volume":"103","author":"SH Wu","year":"2010","unstructured":"Wu SH, Ho SC, Zhong L. Effects of vitamin D supplementation on blood pressure. South Med J. 2010;103:729\u201337.","journal-title":"South Med J"},{"key":"262_CR40","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1210\/jc.2011-0398","volume":"96","author":"MB Elamin","year":"2011","unstructured":"\u2022 Elamin MB, Abu Elnour NO, Elamin KB, et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96:1931\u201342. This is a recent meta-analysis of a large number of intervention trials; it found no significant reduction in overall cardiovascular risk or mortality, or blood pressure, associated with vitamin D supplementation. The authors note significant heterogeneity of study design and analysis and rate the quality of available evidence as low to moderate.","journal-title":"J Clin Endocrinol Metab"},{"key":"262_CR41","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1007\/s00125-006-0426-x","volume":"49","author":"B Littorin","year":"2006","unstructured":"Littorin B, Blow P, Scholin A, et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia. 2006;49:2847\u201352.","journal-title":"Diabetologia"},{"key":"262_CR42","first-page":"w13091","volume":"140","author":"M Janner","year":"2010","unstructured":"Janner M, Ballinari P, Mullis PE, Fluck CE. High prevalence of vitamin D deficiency in children and adolescents with type 1 diabetes. Swiss Med Wkly. 2010;140:w13091.","journal-title":"Swiss Med Wkly"},{"key":"262_CR43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s001250051112","volume":"42","author":"D Vitamin","year":"1999","unstructured":"Vitamin D. supplement in early childhood and risk for Type 1 (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group. Diabetologia. 1999;42:51\u20134.","journal-title":"Diabetologia"},{"key":"262_CR44","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0140-6736(01)06580-1","volume":"358","author":"E Hypponen","year":"2001","unstructured":"Hypponen E, Laara E, Reunanen A, et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001;358:1500\u20133.","journal-title":"Lancet"},{"key":"262_CR45","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/ajcn\/78.6.1128","volume":"78","author":"LC Stene","year":"2003","unstructured":"Stene LC, Joner G, for the Norwegian Childhood Diabetes Study Group. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case\u2013control study. Am J Clin Nutr. 2003;78:1128\u201334.","journal-title":"Am J Clin Nutr"},{"key":"262_CR46","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/adc.2007.128579","volume":"93","author":"CS Zipitis","year":"2008","unstructured":"Zipitis CS, Akobeng AK. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child. 2008;93:512\u20137.","journal-title":"Arch Dis Child"},{"key":"262_CR47","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/ajcn\/79.5.820","volume":"79","author":"KC Chiu","year":"2004","unstructured":"Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and \u03b2 cell dysfunction. Am J Clin Nutr. 2004;79:820\u20135.","journal-title":"Am J Clin Nutr"},{"key":"262_CR48","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.2337\/dc09-2321","volume":"33","author":"S Kayaniyil","year":"2010","unstructured":"Kayaniyil S, Vieth R, Retnakaran R, et al. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care. 2010;33:1379\u201381.","journal-title":"Diabetes Care"},{"key":"262_CR49","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1111\/j.1532-5415.2011.03590.x","volume":"59","author":"V Hirani","year":"2011","unstructured":"Hirani V. Relationship between vitamin D and hyperglycemia in older people from a nationally representative population survey. J Am Geriatr Soc. 2011;59:1786\u201392.","journal-title":"J Am Geriatr Soc"},{"key":"262_CR50","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.2337\/diacare.27.12.2813","volume":"27","author":"R Scragg","year":"2004","unstructured":"Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004;27:2813\u20138.","journal-title":"Diabetes Care"},{"key":"262_CR51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1017\/S0007114511001590","volume":"106","author":"KE Brock","year":"2011","unstructured":"Brock KE, Huang WY, Fraser DR, et al. Diabetes prevalence is associated with serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in US middle-aged Caucasian men and women: a cross-sectional analysis within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Br J Nutr. 2011;106:339\u201344.","journal-title":"Br J Nutr"},{"key":"262_CR52","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.2337\/dc10-0790","volume":"33","author":"AG Pittas","year":"2010","unstructured":"Pittas AG, Sun Q, Manson JE, et al. Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care. 2010;33:2021\u20133.","journal-title":"Diabetes Care"},{"key":"262_CR53","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2337\/diacare.29.03.06.dc05-1961","volume":"29","author":"A Pittas","year":"2006","unstructured":"Pittas A, Dawson-Hughes B, Li T, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care. 2006;29:650\u20136.","journal-title":"Diabetes Care"},{"key":"262_CR54","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.2337\/db11-0465","volume":"60","author":"S Kayaniyil","year":"2011","unstructured":"Kayaniyil S, Retnakaran R, Harris SB, et al. Prospective associations of vitamin D with beta-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study. Diabetes. 2011;60:2947\u201353.","journal-title":"Diabetes"},{"key":"262_CR55","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2337\/dc10-2167","volume":"34","author":"C Gagnon","year":"2011","unstructured":"Gagnon C, Lu ZX, Magliano DJ, et al. Serum 25-dihydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5\u00a0years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care. 2011;34:1133\u20138.","journal-title":"Diabetes Care"},{"key":"262_CR56","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.6250216","volume":"209","author":"AW Norman","year":"1980","unstructured":"Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science. 1980;209:823\u20135.","journal-title":"Science"},{"key":"262_CR57","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2337\/diacare.14.6.505","volume":"14","author":"LM Resnick","year":"1991","unstructured":"Resnick LM. Calcium metabolism in hypertension and allied metabolic disorders. Diabetes Care. 1991;14:505\u201320.","journal-title":"Diabetes Care"},{"key":"262_CR58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/cbf.951","volume":"20","author":"B Maestro","year":"2002","unstructured":"Maestro B, Molero S, Bajo S, et al. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3). Cell Biochem Funct. 2002;20:227\u201332.","journal-title":"Cell Biochem Funct"},{"key":"262_CR59","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1210\/en.2004-1322","volume":"146","author":"CA Gysemans","year":"2005","unstructured":"Gysemans CA, Cardozo AK, Callewaert H, et al. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in non-obese diabetic mice. Endocrinology. 2005;146:1956\u201364.","journal-title":"Endocrinology"},{"key":"262_CR60","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S1357-2725(02)00179-6","volume":"35","author":"PS Leung","year":"2003","unstructured":"Leung PS, Chappell MC. A local pancreatic renin-angiotensin system: endocrine and exocrine roles. Int J Biochem Cell Biol. 2003;35:838\u201346.","journal-title":"Int J Biochem Cell Biol"},{"key":"262_CR61","first-page":"290","volume":"9","author":"KK Leung","year":"2008","unstructured":"Leung KK, Leung PS. Effects of hyperglycemia on angiotensin II receptor type 1 expression and insulin secretion in an INS-1E pancreatic beta-cell line. JOP. 2008;9:290\u20139.","journal-title":"JOP"},{"key":"262_CR62","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/HYPERTENSIONAHA.109.148049","volume":"55","author":"BK Cole","year":"2010","unstructured":"Cole BK, Keller SR, Wu R, et al. Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice. Hypertension. 2010;55:715\u201321.","journal-title":"Hypertension"},{"key":"262_CR63","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2337\/diabetes.55.02.06.db05-1022","volume":"55","author":"KY Chu","year":"2006","unstructured":"Chu KY, Lau T, Carlsson PO, Leung PS. Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes. 2006;55:367\u201374.","journal-title":"Diabetes"},{"key":"262_CR64","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00125-011-2100-1","volume":"54","author":"Q Cheng","year":"2011","unstructured":"Cheng Q, Li YC, Boucher BJ, Leung PS. A novel role for vitamin D: modulation of expression and function of the local renin-angiotensin system in mouse pancreatic islets. Diabetologia 2011;54:2077\u201381.","journal-title":"Diabetologia"},{"key":"262_CR65","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1096\/fj.02-0424fje","volume":"17","author":"U Zeitz","year":"2003","unstructured":"Zeitz U, Weber K, Soegiarto D, et al. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J. 2003;17:509\u201311.","journal-title":"FASEB J"},{"key":"262_CR66","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2337\/db07-1095","volume":"57","author":"C Gysemans","year":"2008","unstructured":"Gysemans C, van Etten E, Overbergh L, et al. Unaltered diabetes presentation in NOD mice lacking the vitamin D receptor. Diabetes. 2008;57:269\u201375.","journal-title":"Diabetes"},{"key":"262_CR67","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jsbmb.2004.03.115","volume":"89\u201390","author":"R Bland","year":"2004","unstructured":"Bland R, Markovic D, Hills CE, et al. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol. 2004;89\u201390:121\u20135.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"262_CR68","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1677\/joe.0.1600087","volume":"160","author":"PM Bourlon","year":"1999","unstructured":"Bourlon PM, Billaudel B, Faure-Dussert A. Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J Endocrinol. 1999;160:87\u201395.","journal-title":"J Endocrinol"},{"key":"262_CR69","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1507\/endocrj.47.383","volume":"47","author":"B Maestro","year":"2000","unstructured":"Maestro B, Campion J, Davila N, Calle C. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endoc J. 2000;47:383\u201391.","journal-title":"Endoc J"},{"key":"262_CR70","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2199-9-65","volume":"9","author":"C Calle","year":"2008","unstructured":"Calle C, Maestro B, Garcia-Arencibia M. Genomic actions of 1,25-dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats. BMC Mol Biol. 2008;9:65.","journal-title":"BMC Mol Biol"},{"key":"262_CR71","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/BF00403372","volume":"37","author":"C Mathieu","year":"1994","unstructured":"Mathieu C, Waer M, Laureys J, et al. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia. 1994;37:552\u20138.","journal-title":"Diabetologia"},{"key":"262_CR72","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.2337\/diabetes.41.11.1491","volume":"41","author":"C Mathieu","year":"1992","unstructured":"Mathieu C, Laureys J, Sobis H, et al. 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes. 1992;41:1491\u20135.","journal-title":"Diabetes"},{"key":"262_CR73","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2337\/diabetes.51.5.1367","volume":"51","author":"S Gregori","year":"2002","unstructured":"Gregori S, Giarratana N, Smiroldo S, et al. 1alpha,25-dihydroxyvitamin D3 analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes. 2002;51:1367\u201374.","journal-title":"Diabetes"},{"key":"262_CR74","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1464-5491.2006.01921.x","volume":"23","author":"D Pitocco","year":"2006","unstructured":"Pitocco D, Crino A, Di Stasio E, et al. The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI). Diabet Med. 2006;23:920\u20133.","journal-title":"Diabet Med"},{"key":"262_CR75","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/dmrr.977","volume":"25","author":"X Li","year":"2009","unstructured":"Li X, Liao L, Yan X, et al. Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA). Diabetes Metab Res Rev. 2009;25:411\u20136.","journal-title":"Diabetes Metab Res Rev"},{"key":"262_CR76","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2337\/dc09-2297","volume":"33","author":"M Walter","year":"2010","unstructured":"Walter M, Kaupper T, Adler K, et al. No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirements in adults with new-onset type 1 diabetes. Diabetes Care. 2010;33:1443\u20138.","journal-title":"Diabetes Care"},{"key":"262_CR77","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.2337\/dc10-0814","volume":"33","author":"C Bizzarri","year":"2010","unstructured":"Bizzarri C, Pitocco D, Napoli N, et al. No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial. Diabetes Care. 2010;33:1962\u20133.","journal-title":"Diabetes Care"},{"key":"262_CR78","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3945\/ajcn.111.011684","volume":"94","author":"J Mitri","year":"2011","unstructured":"Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic \u03b2 cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr. 2011;94:486\u201394.","journal-title":"Am J Clin Nutr"},{"key":"262_CR79","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1742-1241.2003.tb10480.x","volume":"57","author":"AM Borissova","year":"2003","unstructured":"Borissova AM, Tankova T, Kirilov G, et al. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract. 2003;57:258\u201361.","journal-title":"Int J Clin Pract"},{"key":"262_CR80","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.trsl.2011.05.002","volume":"158","author":"S Nazarian","year":"2011","unstructured":"Nazarian S, St Peter JV, Boston RC, et al. Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose. Transl Res. 2011;158:276\u201381.","journal-title":"Transl Res"},{"key":"262_CR81","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1017\/S0007114509992017","volume":"103","author":"PR Hurst von","year":"2009","unstructured":"von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient \u2013 a randomised, placebo-controlled trial. Br J Nutr. 2009;103:549\u201355.","journal-title":"Br J Nutr"},{"key":"262_CR82","doi-asserted-by":"crossref","first-page":"600","DOI":"10.4158\/EP09300.OR","volume":"16","author":"D Parekh","year":"2010","unstructured":"Parekh D, Sarathi V, Shivane VK, et al. Pilot study to evaluate the effect of short-term improvement in vitamin D status on glucose tolerance in patients with type 2 diabetes mellitus. Endocr Pract. 2010;16:600\u20138.","journal-title":"Endocr Pract"},{"key":"262_CR83","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s00125-010-1838-1","volume":"53","author":"MD Witham","year":"2010","unstructured":"Witham MD, Dove FJ, Dryburgh M, et al. The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia. 2010;53:2112\u20139.","journal-title":"Diabetologia"},{"key":"262_CR84","doi-asserted-by":"crossref","first-page":"980","DOI":"10.2337\/dc06-1994","volume":"30","author":"AG Pittas","year":"2007","unstructured":"Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007;30:980\u20136.","journal-title":"Diabetes Care"},{"key":"262_CR85","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/dc07-1829","volume":"31","author":"IH Boer de","year":"2008","unstructured":"de Boer IH, Tinker LF, Connelly S, et al. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women\u2019s Health Initiative. Diabetes Care. 2008;31:701\u20137.","journal-title":"Diabetes Care"},{"key":"262_CR86","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1210\/jc.2007-0298","volume":"92","author":"AG Pittas","year":"2007","unstructured":"Pittas AG, Lau J, Hu FB, et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92:2017\u201329.","journal-title":"J Clin Endocrinol Metab"},{"key":"262_CR87","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.maturitas.2009.12.013","volume":"65","author":"J Parker","year":"2010","unstructured":"Parker J, Hashmi O, Dutton D, et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas. 2010;65:225\u201336.","journal-title":"Maturitas"},{"key":"262_CR88","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/ejcn.2011.118","volume":"65","author":"J Mitri","year":"2011","unstructured":"Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr. 2011;65:1005\u201315.","journal-title":"Eur J Clin Nutr"},{"key":"262_CR89","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ije\/10.4.337","volume":"10","author":"R Scragg","year":"1981","unstructured":"Scragg R. Seasonality of cardiovascular disease mortality and the possible protective effect of ultra-violet radiation. Int J Epidemiol. 1981;10:337\u201341.","journal-title":"Int J Epidemiol"},{"key":"262_CR90","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(89)91634-6","volume":"1","author":"A Fleck","year":"1989","unstructured":"Fleck A. Latitude and ischaemic heart disease. Lancet. 1989;1:613.","journal-title":"Lancet"},{"key":"262_CR91","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archinte.167.11.1159","volume":"167","author":"D Martins","year":"2007","unstructured":"Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007;167:1159\u201365.","journal-title":"Arch Intern Med"},{"key":"262_CR92","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.atherosclerosis.2008.10.033","volume":"205","author":"J Kendrick","year":"2009","unstructured":"Kendrick J, Targher G, Smits G, Chonchol M. 25-hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 2009;205:255\u201360.","journal-title":"Atherosclerosis"},{"key":"262_CR93","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1161\/01.CIR.96.6.1755","volume":"96","author":"KE Watson","year":"1997","unstructured":"Watson KE, Abrolat ML, Malone LL, et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation. 1997;96:1755\u201360.","journal-title":"Circulation"},{"key":"262_CR94","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1681\/ASN.2008111157","volume":"20","author":"IH Boer de","year":"2009","unstructured":"de Boer IH, Kestenbaum B, Shoben AB, et al. 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol. 2009;20:1805\u201312.","journal-title":"J Am Soc Nephrol"},{"key":"262_CR95","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2337\/dc10-0757","volume":"34","author":"KA Young","year":"2011","unstructured":"Young KA, Snell-Bergeon JK, Naik RG, et al. Vitamin D deficiency and coronary artery calcification in subjects with type 1 diabetes. Diabetes Care. 2011;34:454\u20138.","journal-title":"Diabetes Care"},{"key":"262_CR96","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","volume":"117","author":"TJ Wang","year":"2008","unstructured":"Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503\u201311.","journal-title":"Circulation"},{"key":"262_CR97","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/archinte.168.11.1174","volume":"168","author":"E Giovannucci","year":"2008","unstructured":"Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168:1174\u201380.","journal-title":"Arch Intern Med"},{"key":"262_CR98","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.amjcard.2010.05.027","volume":"106","author":"JL Anderson","year":"2010","unstructured":"\u2022 Anderson JL, May HT, Horne BD, et al. for the Intermountain Heart Collaborative (IHC) Study Group. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol. 2010;106:963\u20138. This was a large observational study that provides further evidence for associations between vitamin D levels and cardiovascular disease.","journal-title":"Am J Cardiol"},{"key":"262_CR99","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/j.1532-5415.2009.02359.x","volume":"57","author":"AA Ginde","year":"2009","unstructured":"Ginde AA, Scragg R, Schwartz RS, Camargo Jr CA. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc. 2009;57:1595\u2013603.","journal-title":"J Am Geriatr Soc"},{"key":"262_CR100","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/HJH.0b013e32834e1f0a","volume":"30","author":"G Zhao","year":"2012","unstructured":"\u2022 Zhao G, Ford ES, Li C, Croft JB. Serum 25-hydroxyvitamin D levels and all-cause and cardiovascular disease mortality among US adults with hypertension: the NHANES linked mortality study. J Hypertens. 2012;30:284\u20139. This was a large population-based study linking vitamin D status with both all-cause and cardiovascular-related mortality, noting a strong inverse association between vitamin D level and cardiovascular death.","journal-title":"J Hypertens"},{"key":"262_CR101","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1093\/eurheartj\/ehq246","volume":"31","author":"C Dreschler","year":"2010","unstructured":"Dreschler C, Pilz S, Obermayer-Pietsch B, et al. Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur Heart J. 2010;31:2253\u201361.","journal-title":"Eur Heart J"},{"key":"262_CR102","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/archinte.168.12.1340","volume":"168","author":"H Dobnig","year":"2008","unstructured":"Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168:1340\u20139.","journal-title":"Arch Intern Med"},{"key":"262_CR103","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1210\/jc.2008-0784","volume":"93","author":"S Pilz","year":"2008","unstructured":"Pilz S, Marz W, Wellnitz B, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab. 2008;93:3927\u201335.","journal-title":"J Clin Endocrinol Metab"},{"key":"262_CR104","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3945\/ajcn.111.014779","volume":"95","author":"A Zitterman","year":"2012","unstructured":"Zitterman A, Iodice S, Pilz S, et al. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr. 2012;95:91\u2013100.","journal-title":"Am J Clin Nutr"},{"key":"262_CR105","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/S0006-291X(02)02254-4","volume":"297","author":"H Kasuga","year":"2002","unstructured":"Kasuga H, Hosogane N, Matsuoka K, et al. Characterization of transgenic rats constitutively expressing vitamin D-24-hydroxylase gene. Biochem Biophys Res Commun. 2002;297:1332\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"262_CR106","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1161\/ATVBAHA.110.211805","volume":"30","author":"H Shen","year":"2010","unstructured":"Shen H, Bielak FL, Ferguson JF, et al. Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification. Arterioscler Thromb Vasc Biol. 2010;30:2648\u201354.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"262_CR107","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3945\/ajcn.110.008763","volume":"94","author":"Q Sun","year":"2011","unstructured":"Sun Q, Shi L, Rimm EB, et al. Vitamin D intake and risk of cardiovascular disease in US men and women. Am J Clin Nutr. 2011;94:534\u201342.","journal-title":"Am J Clin Nutr"},{"key":"262_CR108","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.amjcard.2011.09.020","volume":"109","author":"JL Vacek","year":"2012","unstructured":"Vacek JL, Vanga SR, Good M, et al. Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol. 2012;109:359\u201363.","journal-title":"Am J Cardiol"},{"key":"262_CR109","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/gme.0b013e3181d683b5","volume":"17","author":"JE Manson","year":"2010","unstructured":"Manson JE, Allison MA, Carr JJ, et al. Calcium\/vitamin D supplementation and coronary artery calcification in the Women\u2019s Health Initiative. Menopause. 2010;17:683\u201391.","journal-title":"Menopause"},{"key":"262_CR110","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/CIRCULATIONAHA.106.673491","volume":"115","author":"J Hsia","year":"2007","unstructured":"Hsia J, Heiss G, Ren H, et al. Calcium\/vitamin D supplementation and cardiovascular events. Circulation. 2007;115:846\u201354.","journal-title":"Circulation"},{"key":"262_CR111","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/gerona\/glp006","volume":"64","author":"A LaCroix","year":"2009","unstructured":"LaCroix A, Kotchen J, Anderson G, et al. Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women\u2019s Health Initiative calcium-vitamin D randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2009;64:559\u201367.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"262_CR112","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1001\/archinte.167.16.1730","volume":"167","author":"P Autier","year":"2007","unstructured":"Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167:1730\u20137.","journal-title":"Arch Intern Med"},{"key":"262_CR113","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/MOL.0b013e32834d7357","volume":"23","author":"BJ Schueren Van der","year":"2012","unstructured":"Van der Schueren BJ, Verstuyf A, Mathieu C. Straight from D-Heart: vitamin D status and cardiovascular disease. Curr Opin Lipidol. 2012;23:17\u201323.","journal-title":"Curr Opin Lipidol"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-012-0262-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-012-0262-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-012-0262-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T14:36:45Z","timestamp":1687358205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-012-0262-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,30]]},"references-count":113,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["262"],"URL":"https:\/\/doi.org\/10.1007\/s11906-012-0262-y","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,30]]}}}